KRISTEN FRALICH: Open Payments
NPI 1821069261 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 18 payments from 9 companies in 2025. Trend: 2023 $505 · 2024 $690 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| Medtronic, Inc. | 4 | $80 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $55 |
| Abbott Laboratories | 2 | $48 |
| Novo Nordisk Inc | 2 | $36 |
| Amgen Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $21 |
Products named: CAMZYOS, LifeVest, LINQ II, LEQVIO, PERCLOSE PROSTYLE, MITRACLIP, ELIQUIS, Attruby.
Industry payments across IN — which companies pay providers there.
